Physician

Baber Khan, MD

According to 2025 Medicare claims, Baber Khan, MD (NPI: 1073964847) practices neurology in the Cincinnati, OH-KY-IN market, with the plurality of this provider's patient population coming from Kenton, KY. This provider's primary affiliated billing organization is RIVERHILLS HEALTHCARE INC (NPI: 1205943651; TIN: 311412447) and primary practice location at 41017-3410. Khan is affiliated with the Healthcare Solutions Network (ACO ID: A3283), participating under the MSSP model.

Khan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 323 traditional Medicare patients, billed 20,141 HCPCS/CPT codes, and received $564,060 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 1,603 prescription claims across 302 beneficiaries totaling $306,720 in drug costs, led by Gamunex-C (Immune Globul G/Gly/Iga Avg 46). Open Payments data shows 6 records totaling $113. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $1,601 to $564,060. Similarly, Part D prescription costs have moved sharply higher in recent years, from $3,318 to $306,720. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	18	21	$1,601
2021	103	1,381	$47,808
2022	316	13,807	$544,318
2023	353	21,953	$822,810
2024	323	20,141	$564,060

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	14	54	$3,318
2017	21	82	$8,324
2018	53	253	$45,098
2019	35	138	$49,643
2020	38	128	$241,832
2021	57	213	$99,672
2022	116	504	$56,038
2023	209	1,110	$160,111
2024	302	1,603	$306,720

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	55	55	$146
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	46	46	$131
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	68	82	$88
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	90	114	$58
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	36	42	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Gamunex-C	Immune Globul G/Gly/Iga Avg 46	13	364	$149,906
Aimovig Autoinjector	Erenumab-Aooe	41	1,290	$30,808
Emgality Pen	Galcanezumab-Gnlm	21	870	$20,437
Divalproex Sodium	Divalproex Sodium	22	631	$4,165
Carbidopa-Levodopa	Carbidopa/Levodopa	132	8,363	$4,129

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	6	$113	DePuy Synthes Sales Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Baber Khan, MD?

Tedicare shows public-source Medicare data for Baber Khan, MD (NPI 1073964847), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Baber Khan, MD have ACO affiliation data?

Baber Khan, MD is shown with ACO affiliation data for Healthcare Solutions Network (MSSP, ACO ID A3283).

What billing organization is linked to Baber Khan, MD?

Baber Khan, MD is linked to RIVERHILLS HEALTHCARE INC (billing NPI 1205943651) in the available physician profile data.

Does Baber Khan, MD have Open Payments data?

Baber Khan, MD has 6 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.